Attached files

file filename
8-K - FORM 8-K CURRENT REPORT - SIGMA LABS, INC.f8k081117_8k.htm

Sigma Labs logo.jpg 

 

Sigma Labs Announces Financial Results for the Second Quarter Ended June 30, 2017 and Provides Corporate Update

Conference Call To Be Held Today at 4:30pm Eastern Time

 

SANTA FE, N.M. – August 14, 2017 – Sigma Labs, Inc. (NASDAQ: SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced financial results for the three and six months ended June 30, 2017 and provided an overview of recent developments.

 

Second Quarter 2017 Business Highlights and Recent Developments

 

August 2017 – Sigma Labs announced that its cloud-based PrintRite3D® INSPECT® software Version 2.0 was installed at Woodward Inc. (NASDAQ: WWD) Aircraft Turbine Systems group at its Zeeland, MI location. The Company's PrintRite3D® software is part of Woodward's additive manufacturing strategies to ensure that Woodward's aerospace and industrial customers receive quality product.  

August 2017 – Sigma Labs announced signing Jeta Enterprises as a new manufacturer’s representative for sales of Sigma Labs contract printing and additive manufacturing (AM) services in the Pacific Northwest region of the U.S, including Oregon and Washington states. Jeta’s strong customer base in Aerospace and Medical Devices coupled with its expertise in custom-engineered components positions it to serve a growing base of demand for advanced component manufacturing.  

July 2017 – Sigma Labs announced that Mark Cola was appointed as Sigma Labs’ Chief Technology Officer on July 24, 2017, responsible for building and implementing the Sigma Labs technological strategy and guiding key technical advancements towards digitalization in the context of the Industrial Internet of Things (IIoT). Mr. Cola formerly served as President and CEO of Sigma Labs and his new title is President and Chief Technology Officer. Mr. Cola will seek to expand and grow the Company through next-generation products and key customer development in a broad range of industries.  

July 2017 - John Rice, who has served as Chairman of the Board of the Company since his appointment in April 2017, replaced Mr. Cola as CEO. As Chairman and interim CEO, Mr. Rice will oversee Sigma Labs' implementation of internal and external growth, with an emphasis on internal focus technology, sales, and efficiency, and externally, reaching into the marketplace to expand the Company’s digital technical bandwidth with respect to the Company's In-Process Quality Assurance™ (“IPQA®”) technology and AM. Mr. Rice brings substantial operating and investment experience to these tasks, including with respect to operations of startup and emerging companies, corporate finance, and mergers and acquisitions. 

July 2017 – Sigma Labs announced the June 30, 2016 publication of its U.S. Patent Application No. US 2016/0185048; Multi-Sensor Quality Inference and Control for Additive Manufacturing Processes. This patent application is related to real-time quality analysis during AM processes and the characterization of material properties using acoustic signals emitted during AM which can be used in addition to optical signals to simplify the qualification of printed parts. 

July 2017 – Sigma Labs announced that it signed a Technology Development Agreement (TDA) with OXYS Corporation, a technology company in Cambridge, MA working in the Industrie 4.0 space.  The first project to be executed under the TDA will be a new architecture platform for the Company's PrintRite3D® INSPECT. 

June 2017 – Sigma Labs announced that its PrintRite3D® INSPECT® software Version 2.0 was installed at Honeywell Aerospace in Honeywell's Advanced Manufacturing Engineering Center in Phoenix, AZ, in connection with Sigma Labs' ongoing participation in the Honeywell lead, DARPA Phase III. 

June 2017 – Sigma Labs announced that the Company entered into agreements with two additional, non-exclusive sales agents in the Asia Pacific region, driven by strong customer interest in the region for PrintRite3D®. One such agent, Enervision Inc., will target the high growth expectations in the South Korean AM market, driven by the Korean government's announcement in April 2017 of a $37 million investment to accelerate the development of 3D printing across the country.  Sigma Labs' other new sales agent, Beijing Yida Sifang Technology Co., Ltd, a leading metal AM reseller with multiple offices in China, will assist Sigma Labs with its expansion into the China AM market.   



“We are implementing our strategic double down on both Sigma Labs' technology and also on our ongoing efforts to grow Sigma Labs into a robust digital 3D ecosystem by seeking to identify compatible businesses to potentially acquire that will be synergistic with Sigma Labs' technology and business, although there are currently no agreements with respect to the acquisition by the Company of any third party, and there is no assurance than any acquisition will be consummated. In July and early August 2017, we changed our management lineup to add more capacity to implement our strategy. We believe that we have excellent technology and are supported by an excellent team of technologists. We also believe that we have accomplished a hard-won understanding of a rapidly changing market place, and that our early adopter and OEM strategies are gaining traction. We know that we need to perform better operationally, and are reconstituting senior management and the Board to focus on three very defined targets: (1) product development, sales, and support; (2) business operations; and (3) expansion through the exploration of various business opportunities," said John Rice, interim CEO.

 

Second Quarter Ended June 30, 2017 Financial Results

 

Revenue for the three months ended June 30, 2017, was $290,553, as compared to revenue of $93,824 during the same period in 2016. The increase in revenue was primarily due to new contracts in 2017, including Honeywell DARPA Phase III, Aerojet Rocketdyne, and Solar Turbines, Pratt and Whitney, and Woodward which accounted for the majority of the $196,729 increase in revenues when comparing Q2 2017 to Q2 2016. In addition, the Q2 2016 revenues were lower due to the completion of the GEA America Makes Program in Q1 2016, providing no revenues from that contract in Q2 2016.

 

General and Administrative expenses for the three months ended June 30, 2017, were $594,193, as compared to $480,697 for the same period in 2016.  The $113,496 increase was primarily due to increases in legal fees and the increase in interest and finance costs on the $1,000,000 promissory note originated in October 2016. Payroll expenses for the three months ended June 30, 2017, were $300,661, as compared to $252,895 for the same period in 2016. The $47,766 increase was due to an increase in employees in Q2 2017 versus Q2 2016. Expenses relating to stock-based compensation for the three months ended June 30, 2017, were $166,773, as compared to $59,362 for the same period in 2016. The $107,411 increase was due to more stock and stock options being used to pay for services as a mechanism to preserve cash. Research and Development expenses for the three months ended June 30, 2017, were $118,853, as compared to $11,907 for the same period in 2016. The $106,946 increase was the result of continued improvement and development of the Company's software and technology.

 

Net loss for the three months ended June 30, 2017 increased $246,895 and totaled $988,741, as compared to $741,846 for the same period in 2016. The increase is primarily due to the $375,619 increase in expenses noted above, partially offset by the $116,221 increase in gross profits, which is primarily due to the $196,729 increase in revenues in Q2 2017 compared to Q2 2016.

 

Revenue for the six months ended June 30, 2017, was $440,756, as compared to $452,279 recognized during the same period in 2016. The $11,523 decrease in revenue was primarily due to the completion of the GEA America Makes Program in 2016, providing three months of revenue in 2016 but no revenue in 2017. However, new business in Q2 2017 from customers like Honeywell DARPA Phase III, Aerojet Rocketdyne and Solar Turbines made up for the majority of the reduction that resulted from the completion of the GEA America Makes Program. The Company financed its operations during the six months ended June 30, 2017 and 2016 primarily from PrintRite3D® system sales, DARPA Phase III, Aerojet Rocketdyne and Solar Turbines programs, engineering consulting services provided to third parties, and through sales of the Company's common stock and debt securities.

 

General and Administrative expenses for the six months ended June 30, 2017, were $1,237,988, as compared to $876,185 for the same period in 2016. The costs of the February 2017 public offering that generated net proceeds of approximately $5.25 million, legal fees, and the interest and finance costs related to the Company's $1,000,000 note, are the primary reasons for the $361,803 increase in G&A expenses. Payroll expenses for the six months ended June 30, 2017, were $677,282, as compared to $468,484 for the same period in 2016. Employee additions are the main reason for the $208,798 payroll expense increase. Expenses relating to stock-based compensation for the six months ended June 30, 2017, were $306,405, as compared to $130,913 for the same period in 2016. The $175,492 increase is the result of using stock and stock options to pay for services in order to preserve cash. Research and Development expenses for the six months ended June 30, 2017, were $167,615, as compared to $50,978 for the same period in 2016. The $116,637 increase is the result of increased efforts to continue to develop and improve the Company's software and technology.

 

Net loss for the six months ended June 30, 2017, increased $720,193 over the prior year and totaled $1,932,706 as compared to $1,212,513 for the same period in 2016. While revenue decreased $11,523, the Company experienced an $862,730 net increase in expenses. The Company recorded other income of $201,774, primarily from the receipt of New Mexico state employee incentives, and non-cash income and expenses related to derivative liabilities and debt discounts.



As of June 30, 2017, the Company had $3,384,499 in cash on its balance sheet, compared to $398,391 in cash as of June 30, 2016 and a working capital surplus of $3,374,359 as of June 30, 2017, compared to a working capital surplus of $110,799 as of June 30, 2016.

 

Investor Conference Call

 

Management will host a conference call today, Monday, August 14, 2017 at 4:30pm to review financial results and corporate highlights. Following management’s formal remarks, there will be a question and answer session. To listen to the call by phone, interested parties within the U.S. should call 1-877-344-7529 and International callers should call 1-412-317-5134. All callers should ask for the Sigma Labs conference call. The conference call will also be available through a live webcast at www.sigmalabsinc.com. Details for the webcast may be found on the Company’s IR events page at http://client.irwebkit.com/sigmalabsinc/events. A replay of the call will be available approximately one hour after the end of the call through September 14, 2017. The replay can be accessed via Sigma Labs' website or by dialing 877-344-7529 (domestic) or 412-317-0088 (international) or Canada Toll Free at 855-669-9658. The replay conference ID number is 10111326. The webcast replay will be available through November 14, 2017.  

 

About Sigma Labs, Inc.

 

Sigma Labs, Inc. is a provider of quality assurance software under the PrintRite3D® brand and a developer of advanced, in-process, non-destructive quality assurance software for commercial firms worldwide seeking productive solutions for advanced manufacturing. For more information please visit us at www.sigmalabsinc.com.  

 

Forward-Looking Statements

 

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Annual Report on Form 10-K (including but not limited to the discussion under “Risk Factors” therein) filed with the SEC on March 31, 2017 and which may be viewed at http://www.sec.gov.

 

Investor Relations Contact:

Bret Shapiro

Managing Director

CORE IR

561-479-8566

brets@coreir.com



Sigma Labs, Inc.

Condensed Balance Sheets

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

June 30,

2017

 

December 31,

2016

 

 

 

 

 

ASSETS

 

 

 

 

Current Assets:

 

 

 

 

Cash

$

3,384,499

$

398,391

Accounts Receivable, net

 

235,467

 

288,236

Note Receivable, net

 

762,034

 

-

Inventory

 

227,827

 

187,241

Prepaid Assets

 

37,176

 

36,056

Total Current Assets

 

4,647,003

 

909,924

 

 

 

 

 

Other Assets:

 

 

 

 

Property and Equipment, net

 

491,188

 

564,933

Intangible Assets, net

 

241,978

 

226,450

Investment in Joint Venture

 

500

 

500

Prepaid Stock Compensation

 

111,070

 

167,562

Total Other Assets

 

844,736

 

959,445

 

 

 

 

 

TOTAL ASSETS

$

5,491,739

$

1,869,369

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

Current Liabilities:

 

 

 

 

Accounts Payable

$

137,605

$

112,175

Notes Payable, net of original issue discount $30,297 at

June 30, 2017 and net of original issue discount $69,703

and net of debt discount $358,280 at December 31, 2016

 

969,703

 

561,834

Accrued Expenses

 

165,336

 

125,116

Total Current Liabilities

 

1,272,644

 

799,125

 

 

 

 

 

Long-Term Liabilities

 

 

 

 

Derivative Liability

 

-

 

93,206

Total Long-Term Liability

 

-

 

93,206

 

 

 

 

 

TOTAL LIABILITIES

 

1,272,644

 

892,331

 

 

 

 

 

Stockholders' Equity

 

 

 

 

Preferred Stock, $0.001 par; 10,000,000 shares authorized;

None issued and outstanding

 

-

 

-

Common Stock, $0.001 par; 7,500,000 shares authorized;

4,570,199 and 3,133,789 issued and outstanding at

June 30, 2017 and 2016, respectively

 

4,570

 

3,135

Additional Paid-In Capital

 

15,908,185

 

10,734,857

Accumulated Deficit

 

(11,693,660)

 

(9,760,954)

Total Stockholders' Equity

 

4,219,095

 

977,038

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$

5,491,739

$

1,869,369



Sigma Labs, Inc.

Condensed Statements of Operations

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

June 30,

2017

 

June 30,

2016

 

June 30,

2017

 

June 30,

2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

$

290,553

$

93,824

$

440,756

$

452,279

 

 

 

 

 

 

 

 

 

COST OF REVENUE

 

111,412

 

30,904

 

185,946

 

138,485

 

 

-

 

 

 

 

 

 

GROSS PROFIT

 

179,141

 

62,920

 

254,810

 

313,794

 

 

 

 

 

 

 

 

 

EXPENSES:

 

 

 

 

 

 

 

 

Other General and Administration

 

594,193

 

480,697

 

1,237,988

 

876,185

Payroll Expense

 

300,661

 

252,895

 

677,282

 

468,484

Stock-Based Compensation

 

166,773

 

59,362

 

306,405

 

130,913

Research and Development

 

118,853

 

11,907

 

167,615

 

50,978

Total Expenses

 

1,180,480

 

804,861

 

2,389,290

 

1,526,560

 

 

 

 

 

 

 

 

 

OTHER INCOME (EXPENSE)

 

 

 

 

 

 

 

 

Interest Income

 

12,598

 

95

 

12,941

 

253

Other Income

 

-

 

-

 

152,068

 

-

Other Income-Decrease in fair value of derivative

liabilities

 

-

 

-

 

93,206

 

-

Other Expense - Debt discount amortization

 

-

 

-

 

(56,441)

 

-

Total Other Income

 

12,598

 

95

 

201,774

 

253

 

 

-

 

 

 

 

 

 

LOSS BEFORE PROVISION FOR INCOME TAXES

 

(988,741)

 

(741,846)

 

(1,932,706)

 

(1,212,513)

 

 

-

 

-

 

-

 

-

Provision for income Taxes

 

-

 

-

 

-

 

-

 

 

-

 

-

 

-

 

-

Net Loss

$

(988,741)

$

(741,846)

$

(1,932,706)

$

(1,212,513)

 

 

 

 

 

 

 

 

 

Net Loss per Common Share - Basic and Diluted

$

(0.24)

$

(0.24)

$

(0.46)

$

(0.38)

 

 

 

 

 

 

 

 

 

Weighted Average Number of Shares

 

 

 

 

 

 

 

 

Outstanding - Basic and Diluted

 

4,570,199

 

3,117,851

 

4,207,116

 

3,117,851



Sigma Labs, Inc.

Condensed Statements of Cash Flows

(Unaudited)

 

 

 

 

 

 

 

Six Months ended

 

 

2017

 

2016

OPERATING ACTIVITIES

 

 

 

 

Net Loss

$

(1,932,706)

$

(1,212,513)

Adjustments to reconcile Net Income (Loss) to Net Cash used in operating activities:

 

 

 

 

Noncash Expenses:

 

 

 

 

Amortization

 

6,526

 

5,764

Depreciation

 

85,125

 

87,054

Stock Compensation

 

307,445

 

130,913

Loss on Joint Venture

 

-

 

103

Revaluation of derivative liability and debt discount related to notes payable

 

(93,206)

 

-

Note payable original issue discount

 

49,589

 

-

Note payable debt discount amortization

 

56,441

 

-

Change in assets and liabilities:

 

 

 

 

Accounts Receivable

 

52,769

 

27,564

Inventory

 

(40,586)

 

(70,765)

Prepaid Assets

 

(1,120)

 

7,344

Accounts Payable

 

25,430

 

63,974

Accrued Expenses

 

40,220

 

46,006

NET CASH USED IN OPERATING ACTIVITIES

 

(1,444,073)

 

(914,556)

 

 

 

 

 

INVESTING ACTIVITIES

 

 

 

 

Purchase of Furniture and Equipment

 

(11,380)

 

(25,430)

Purchase of Intangible Assets

 

(22,054)

 

(46,835)

Notes receivable

 

(762,034)

 

-

NET CASH USED IN INVESTING ACTIVITIES

 

(795,468)

 

(72,265)

 

 

 

 

 

FINANCING ACTIVITIES

 

 

 

 

Proceeds from issuance of common stock and warrants

 

5,225,649

 

-

NET CASH PROVIDED BY FINANCING ACTIVITIES

 

5,225,649

 

-

 

 

 

 

 

NET CASH DECREASE FOR PERIOD

 

2,986,108

 

(986,821)

 

 

 

 

 

CASH AT BEGINNING OF PERIOD

 

398,391

 

1,539,809

 

 

 

 

 

CASH AT END OF PERIOD

$

3,384,499

$

552,988

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information:

 

 

 

 

Cash paid during the period for:

 

 

 

 

Interest

$

50,418

$

-

Income Taxes

$

-

$

-

 

 

 

 

 

Supplemental Schedule of Noncash Investing and Financing Activities:

 

 

 

 

Issuance of Common Stock for services

$

51,408

$

44,998